Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Smriti Irani's Story: From McDonald's Floors To Parliament & Back To Acting
Rishab Shetty Charges 2400% More For Kantara Chapter 1 After Previous Film's Success - Check Out His Fees
Maharashtra Minister Pratap Sarnaik Heckled By MNS Workers During Protest Over Marathi Language Row (VIDEO)
Real Estate Company Omaxe Buys 450-Acre Land In Indore To Develop Township At An Investment Of ₹
1,200 Crore
(With inputs from PTI)
